The reason Children’s Medical Research Institute (CMRI) exists is to find ways to treat or prevent childhood disease. Our research programs are focussed on the areas of cancer cell growth, nerve cell signalling, embryology and gene therapy. These four programs have a shared aim of translating novel findings into new treatments for the benefit of families everywhere.
[More]
Leica Microsystems and TrueVision® 3D Surgical announced today that key components of the TrueVision® 3D intelligent digital visualization and guidance platform have been integrated with select future models of Leica Microsystems’ ophthalmic surgical microscopes and will be marketed under the Leica brand.
[More]
The Ramaciotti Foundations will award nearly $645,000 in grants to nine Sydney researchers at a gala dinner tonight, to support continued outstanding biomedical research. The Ramaciotti Foundations will award over $1.6 million to 23 recipients at the annual awards evening in Brisbane.
[More]
MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.
[More]
Next week NPS will host its inaugural webinar for GPs looking at medical imaging in respiratory tract infections (RTIs). Forming part of the NPS campaign on antibiotic resistance, the webinar on 10 May enables GPs to engage with imaging experts in real-time and gain insights into when imaging is appropriate for RTIs.
[More]
Reliable and highly accurate raw data is needed to use 3D images of a person or object, for example for body measurement. The VITUS smart body scanner from VITRONIC generates an accurate 3D image during a scan of only 12 seconds. VITRONIC will present the VITUS smart body scanner at the 3D Body Scanning Technologies Asian Workshop in Tokyo, Japan.
[More]
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.’s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow’s treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.
[More]
Malignant melanoma (MM), the most dangerous type of skin cancer, is caused mainly by intense episodes of UV exposure and originates in the pigment-producing melanocytes in the basal layer of the epidermis. Early detection and complete excision of the primary lesions is crucial for reducing melanoma-related deaths but current diagnostic practice is highly subjective. This leads to unnecessary surgical procedures, which are highly-invasive and expensive.
[More]
Akeso Medical Imaging BV, announces today the start of a clinical study with their novel imaging device for assessment of joint inflammation in patient with rheumatoid arthritis (RA). In this proof of concept study, Akeso’s imaging device will be compared to other methods to assess disease status, such as the DAS-28 score, Ultrasound and in some cases MRI. The study will be performed at the University Medical Center Utrecht (UMC Utrecht) in cooperation with Regional Rheumatology Centre Eindhoven (RRC). Seventy subjects will be included; sixty RA patients with varying degrees of inflammation of the joints of hands and wrists at the time of examination and a control group of ten subjects.
[More]
For over a decade, GE Healthcare has partnered with academic researchers from Purdue, Notre Dame and Michigan, and experts from Intel, to develop Veo – the world’s first Model-Based Iterative Reconstruction (MBiR) technique. Available on GE’s Discovery CT750 HD, Veo changes the rules of CT imaging by helping physicians provide accurate diagnoses with high quality images while enabling them to lower patients’ radiation dose levels.
[More]
GE Global Research, the central technology development arm for GE Healthcare and all of GE's businesses, has signed a Memorandum of Understanding (MOU) with Singapore's Agency of Science, Technology and Research (A*STAR). This agreement will focus on advancing current medical imaging technologies and diagnostics to enable more accurate, earlier and faster clinical diagnoses of cancer and other diseases. The partnership between A*STAR and GE Global Research brings together two world-class research institutions, integrating their deep domain expertise in biomedical, science, and engineering capabilities to support this effort.
[More]
The Nano BioDiscovery™ Division of NanoInk®, Inc. announced today the release of a new automated platform for the analysis of its protein NanoArray assays. NanoInk’s NanoArray Assay System™ enables detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology.
[More]
Royal Philips Electronics NV has received approval from U.S. regulators to introduce a single medical imaging device that can scan the body for cancer using two technologies.
[More]
QUBYX has announced the official release of the new version 3 of its medical display calibration and verification software PerfectLum. The software is designed to improve imaging precision of medical monitors, used for X-Ray viewing, mammoghraphy, MRI and other radiology subindustries, and is based on such standards, as NEMA DICOM part 14 GSDF, AAPM TG18, DIN 6868-57, JESRA X-0093 and IEC 62563-1.
[More]
Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, announces the acquisition of Platinum Medical Imaging LLC (“Platinum”).
[More]
Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for researchers worldwide. The agreement provides researchers with improved access to a large, diverse portfolio of translational models for use in pre-clinical oncology studies, along with supporting scientific services.
[More]
Leica Microsystems announce the launch of its clinical workflow solution for Digital Pathology at Pathology Visions 2011. Digital Image Hub Enterprise* with its powerful image management, integration and communication capabilities, in conjunction with a new high performance, intuitive client viewer, SlidePath Gateway*, combine to make this the ideal solution for clinical centers moving towards true Digital Pathology implementation. Furthermore, Leica’s Total Digital Pathology solutions now provide an implementation of the DICOM Supplement 145 standard for both slide scanning and viewing.
[More]
The University of Sydney, in partnership with BreastScreen NSW and Ziltron, has developed a pioneering web-based programme to monitor the performance of radiologists in detecting and diagnosing abnormalities in breast x-rays. Currently commencing its nationwide rollout, the BREAST Project has the potential to improve the early detection of breast cancer through screening and in turn reduce breast cancer mortality and morbidity.
[More]
Akeso Medical Imaging BV, a spin-off from Philips Research, announces today the closure of its first financing round led by Thuja Capital Healthcare Seed Fund with additional financing from the Brabant Spin-Off Fund and Point-One Innovation Fund.
[More]
GE Healthcare has announced today the availability of HDlive and Volume SRI (Speckle Reduction Imaging) for women’s health imaging products within its Voluson Expert series platform. These innovations are being showcased for the first time in the United States at the 2011 International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) congress in Los Angeles.
[More]